Sanjivani Paranteral Limited (SANJIVIN) Share Price
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE860D01013
Key metrics
- Market Cap
- ₹237 Cr
- P/E Ratio
- 33.62
- EPS
- 6.07
- Book Value
- 41.39
- P/B Ratio
- 4.65
- ROE
- 13.17%
- ROCE
- 13.96%
- Debt / Equity
- 0.28
- Net Margin
- 9.75%
- Revenue Growth
- -2.04%
- Profit Growth
- -17.3%
- Dividend Yield
- 0.26%
- 52W High
- ₹268.00
- 52W Low
- ₹126.00
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Sanjivani Paranteral Limited
Sanjivani Paranteral Limited operates as a pharmaceutical company in India. The company manufactures pharmaceutical products in the form of oral solids, small volume parenteral, and sterile powder formulations for various therapeutic areas, including central nervous system, cardiovascular system, antibiotics, gastroenterological, anti-diabetics, and anti-allergic. It also offers soft gels, such as multivitamins; topicals comprising corticosteroids, antiseptics, NSAIDs, anti-fungal, and anti-bacterial; nasal sprays; liquid and dry powder injections covering antibiotics, anti-emetic, NSAID and analgesic, antimalarial, and proton pump inhibitor and H2 receptor antagonist; capsules and tablets, including antibiotic, antifungal, anticonvulsant, multivitamins, and NSAID and analgesic; dry syrups; and ear/eye drops. In addition, the company exports its products. Sanjivani Paranteral Limited was incorporated in 1994 and is headquartered in Mumbai, India.
- Headquarters
- Mumbai, India
- Promoter Holding
- 59.51%
The full Sanjivani Paranteral Limited analysis
Create a free account to open the complete SANJIVIN deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.